Prediction of week 4 virological response in hepatitis C for making decision on triple therapy: the Optim study.

Prediction of week 4 virological response in hepatitis C for making decision on triple therapy: the Optim study.

Virological response to peginterferon + ribavirin (P+R) at week 4 can predict sustained virological response (SVR). While patients with rapid virological response (RVR) do not require triple therapy, patients with a decline <1 log10 IU/ml HCVRNA (D1L) should have treatment discontinued due to low...

Full description

Bibliographic Details
Main Authors: Manuel Romero-Gómez, Juan Turnes, Javier Ampuero, Itziar Oyagüez, Beatriz Cuenca, Juan Gonzalez-Garcia, Belén Muñoz-Molina, Rocio Aguilar, Sandra Leal, Ramon Planas, Javier Garcia-Samaniego, Moises Diago, Javier Crespo, Jose Luis Calleja, Miguel Angel Casado, Ricard Sola
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2015-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC4426774?pdf=render

Internet

http://europepmc.org/articles/PMC4426774?pdf=render

Similar Items